Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $133.1400 (0.35%) ($131.8800 - $133.6200) on Wed. Aug. 3, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.88% (three month average) | RSI | 59 | Latest Price | $133.1400(0.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.4% a day on average for past five trading days. | Weekly Trend | LGND advances 2.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(56%) XBI(56%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -0.94% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) IPO(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.94% (StdDev 1.88%) | Hourly BBV | 0 () | Intraday Trend | 0.2% | | | |
|
5 Day Moving Average | $134.82(-1.25%) | 10 Day Moving Average | $134.3(-0.86%) | 20 Day Moving Average | $131.04(1.6%) | To recent high | -3.9% | To recent low | 19.1% | Market Cap | $2.14b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |